Literature DB >> 4804275

Evaluation of host immunity in human neoplasia. 1. Discussion.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4804275      PMCID： PMC2149062     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  9 in total

1.  Immunoprophylaxis and immunotherapy of leukaemia with B.C.G.

Authors:  J Z Finklestein; K L Tittle; D T Imagawa
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

2.  The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.

Authors:  P A Ward; H G Remold; J R David
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

3.  The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon.

Authors:  T H Stewart
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

4.  Effects of antitumour immunity on pregnancy in the mouse.

Authors:  G Parmiani; G Della Porta
Journal:  Nat New Biol       Date:  1973-01-03

5.  Mitomycin C inactivation of leukocytes in the mixed leukocyte culture.

Authors:  E E Etheredge; A R Shons; K L Hohenthaner; J S Najarian
Journal:  Transplantation       Date:  1973-03       Impact factor: 4.939

6.  Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

7.  The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon.

Authors:  T H Stewart
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

8.  Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.

Authors:  H G Remold; A B Katz; E Haber; J R David
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

9.  Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors:  E J Field; E A Caspary
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.